Back to results
US 2025/0144009 A1Published application
Topical formulations comprising tofacitinib
AssigneeTWi Biotechnology, Inc.
InventorsChih-Ming Chen, Guang-Wei Lu, Ling-Ying Liaw, Fan-Lun Liu, Shih-Fen Liao, Chou-Hsiung Chen, Yu-Han Kao, Yu-Yin Chen
Life of this patent
Estimating the term…
Abstract
A topical formulation comprising (a) a therapeutically effective amount of tofacitinib; (b) at least one solvent; and (c) optionally one or more other pharmaceutically acceptable excipients is provided. Also provided is a method for treating and/or preventing autoimmune diseases in a subject administering said topical formulation.
Claims21
A topical formulation comprising:
- (a) a therapeutically effective amount of tofacitinib;
- (b) at least one solvent;
- and
- (c) optionally one or more other pharmaceutically acceptable excipients.
1 more element
A topical formulation, comprising:
- (a) a therapeutically effective amount of tofacitinib citrate;
- (b) dimethyl sulfoxide;
- (c) optionally, propylene glycol;
- (d) optionally, a thickening agent;
- (e) optionally, an antioxidant;
- and
- (f) optionally, one or more other pharmaceutically acceptable excipients.
4 more elements
Dependencies are inferred from the claim text.